---
figid: PMC10310677__40120_2023_474_Fig6_HTML
pmcid: PMC10310677
image_filename: 40120_2023_474_Fig6_HTML.jpg
figure_link: /pmc/articles/PMC10310677/figure/Fig6/
number: Fig. 6
figure_title: ''
caption: Proportion of patients who received an alternative primary diagnosis before
  receiving a MOGAD diagnosis*. *Survey Question 17; data from 204 respondents. MOGAD
  myelin oligodendrocyte glycoprotein antibody-associated disease
article_title: 'Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein
  Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204
  Patients.'
citation: Jonathan D. Santoro, et al. Neurol Ther. 2023 Aug;12(4):1081-1101.
year: '2023'

doi: 10.1007/s40120-023-00474-9
journal_title: Neurology and Therapy
journal_nlm_ta: Neurol Ther
publisher_name: Springer Healthcare

keywords:
- Demyelination
- Diagnosis
- Myelin oligodendrocyte glycoprotein (MOG)
- Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)
- Neurology
- Patient perspective
- Survey
- Symptoms

---
